Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Terminated 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Motor Activity 9Neoplasms 4Breast Neoplasms 3Weight Loss 2Ventricular Dysfunction, Left 1Urinary Incontinence 1Sexual Dysfunction, Physiological 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Melanoma 1Lymphoma 1Leukemia 1Insulin Resistance 1Hypoxia 1Hematologic Neoplasms 1Heart Failure 1Head and Neck Neoplasms 1Fecal Incontinence 1Fatigue 1Cardiotoxicity 1Carcinoma, Renal Cell 1Cachexia 1Brenner Tumor 1Breast Diseases 1Brain Neoplasms 1Bone Metastases 1Body Weight 1

Interventions

Doxorubicin 5Cyclophosphamide 3Trastuzumab 2Docetaxel 2Dexrazoxane 2empagliflozin 1Taxes 1Tamoxifen 1Razoxane 1Radiotherapy 1Radiation 1Paclitaxel 1Neoadjuvant Therapy 1Methotrexate 1Metformin 1Leucovorin 1High-Intensity Interval Training 1Hematologic Tests 1Filgrastim 1Exercise 1Epirubicin 1Echocardiography 1Cisplatin 1Chemotherapy, Adjuvant 1Carvedilol 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Cardiotoxicity × Exercise × Clear all
NCT03850171 2023-02-27

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Insel Gruppe AG, University Hospital Bern

Phase NA Terminated
57 enrolled
BreastLymphoid

Breast Diseases, Breast Neoplasms, Heart Failure, Lymphoma, Motor Activity, Ventricular Dysfunction, Left, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡